These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6418109)

  • 1. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C; Cournoyer G; Morissette R; Langlois R; Caillé G
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1983 Dec; 40(12):1335-42. PubMed ID: 6418110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study.
    de Montigny C; Elie R; Caillé G
    Am J Psychiatry; 1985 Feb; 142(2):220-3. PubMed ID: 3918468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC; Mayo JP; Gillette GM; Little KY; Mason GA
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A; Ginath Y
    Harefuah; 1991 Dec; 121(11):429-30. PubMed ID: 1786889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T3 and lithium potentiation of tricyclic antidepressants.
    Joffe RT
    Am J Psychiatry; 1988 Oct; 145(10):1317-8. PubMed ID: 3138921
    [No Abstract]   [Full Text] [Related]  

  • 8. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of the tricyclic-induced switch in bipolar manic-depression.
    Waters BG; Lapierre YD
    Am J Psychiatry; 1982 Feb; 139(2):245-6. PubMed ID: 6798886
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders.
    Dé Montigny C; Grunberg F; Mayer A; Deschenes JP
    Br J Psychiatry; 1981 Mar; 138():252-6. PubMed ID: 7272619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
    Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
    Kramlinger KG; Post RM
    Arch Gen Psychiatry; 1989 Sep; 46(9):794-800. PubMed ID: 2505730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants].
    Cournoyer J
    Can J Psychiatry; 1986 May; 31(4):335-8. PubMed ID: 3085912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.
    Prien RF; Kupfer DJ; Mansky PA; Small JG; Tuason VB; Voss CB; Johnson WE
    Arch Gen Psychiatry; 1984 Nov; 41(11):1096-104. PubMed ID: 6437366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
    J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders.
    Dinan TG; Barry S
    Acta Psychiatr Scand; 1989 Jul; 80(1):97-100. PubMed ID: 2504034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients.
    Ebert D; Jaspert A; Murata H; Kaschka WP
    Psychopharmacology (Berl); 1995 Mar; 118(2):223-5. PubMed ID: 7617812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.
    Schöpf J; Baumann P; Lemarchand T; Rey M
    Pharmacopsychiatry; 1989 Sep; 22(5):183-7. PubMed ID: 2682692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.